Epivir A/F and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
Determining the interaction of Epivir A/F and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lamivudine
Brand name: Epivir, Epivir HBV
Synonyms: Lamivudine, LamiVUDine
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Epivir A/F-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Epivir A/F-Kitabis Pak
- Epivir A/F-Kitabis Pak inhalation
- Epivir A/F-Klofensaid II
- Epivir A/F-Klonopin
- Epivir A/F-Klonopin Wafer
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Epivir HBV
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Epivir-HBV (Lamivudine Oral Solution)
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Epivir-HBV (Lamivudine Tablets)
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Eplerenone
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Epoetin alfa
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Epoetin alfa Injection